{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:20:20Z","timestamp":1792786820232,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T00:00:00Z","timestamp":1553904000000},"content-version":"am","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Pittsburgh Tissue Engineering Initiative Seed Grant","id":[{"id":"https:\/\/ror.org\/0336jnw26","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000005","name":"DOD","doi-asserted-by":"publisher","award":["FA8650-17-2-6836"],"award-info":[{"award-number":["FA8650-17-2-6836"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","award":["1R21DA039621-01"],"award-info":[{"award-number":["1R21DA039621-01"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"NIBIB","doi-asserted-by":"publisher","award":["R21EB023104-02"],"award-info":[{"award-number":["R21EB023104-02"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AFMSA","award":["FA8650-17-2-6836"],"award-info":[{"award-number":["FA8650-17-2-6836"]}]},{"name":"Pittsburgh Tissue Engineering Initiative Seed Grant","id":[{"id":"https:\/\/ror.org\/0336jnw26","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DBI-1726368"],"award-info":[{"award-number":["DBI-1726368"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hunkele Dreaded Disease Award"},{"name":"Samuel and Emma Winters Foundation"},{"name":"Charles Henry Leach II Fund"},{"name":"Commonwealth Universal Research Enhancement Award"},{"DOI":"10.13039\/100000001","name":"NSF","doi-asserted-by":"publisher","award":["DBI-0400776"],"award-info":[{"award-number":["DBI-0400776"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"Center for Biologic Imaging, University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1S10OD019973-01"],"award-info":[{"award-number":["1S10OD019973-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009854","name":"Duquesne University Inaugural Provost's Interdisciplinary Research Consortia Grant","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009854","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pain Undergraduate Research Experience"},{"name":"Chronic Pain Research Consortium"},{"name":"Charles Henry Leach II Fund"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jneuroim.2018.02.010","type":"journal-article","created":{"date-parts":[[2018,2,25]],"date-time":"2018-02-25T10:28:06Z","timestamp":1519554486000},"page":"72-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Low-dose NSAIDs reduce pain via macrophage targeted nanoemulsion delivery to neuroinflammation of the sciatic nerve in rat"],"prefix":"10.1016","volume":"318","author":[{"given":"Jelena M.","family":"Janjic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Vasudeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9910-136X","authenticated-orcid":false,"given":"Muzamil","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sravan","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jneuroim.2018.02.010_bb0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2146\/ajhp130336","article-title":"Additives to local anesthetics for peripheral nerve blocks: evidence, limitations, and recommendations","volume":"71","author":"Bailard","year":"2014","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"1","key":"10.1016\/j.jneuroim.2018.02.010_bb0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jneuroim.2018.02.010_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3940(94)11154-B","article-title":"Role of peri-axonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain","volume":"184","author":"Clatworthy","year":"1995","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.jneuroim.2018.02.010_bb0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.aanat.2011.02.011","article-title":"Wallerian degeneration and peripheral nerve conditions for both axonal regeneration and neuropathic pain induction","volume":"193","author":"Dubov\u00fd","year":"2011","journal-title":"Ann. Anat. Anatomischer Anzeiger"},{"issue":"1","key":"10.1016\/j.jneuroim.2018.02.010_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-6-1","article-title":"Prostanoid receptor EP1 and Cox-2 in injured human nerves and a rat model of nerve injury: a time-course study","volume":"6","author":"Durrenberger","year":"2006","journal-title":"BMC Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2018.02.010_bb0030","doi-asserted-by":"crossref","first-page":"i97","DOI":"10.1093\/bja\/aeq273","article-title":"Complications of peripheral nerve blocks","volume":"105","author":"Jeng","year":"2010","journal-title":"Br. J. Anaesth."},{"issue":"5","key":"10.1016\/j.jneuroim.2018.02.010_bb0035","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1517\/17425247.2012.668523","article-title":"Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs","volume":"9","author":"Kotta","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"issue":"3","key":"10.1016\/j.jneuroim.2018.02.010_bb0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40005-013-0067-2","article-title":"Enhanced dissolution rate of celecoxib using PVP and\/or HPMC-based solid dispersions prepared by spray drying method","volume":"43","author":"Lee","year":"2013","journal-title":"J. Pharm. Invest."},{"issue":"1","key":"10.1016\/j.jneuroim.2018.02.010_bb0045","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1089\/biores.2014.0030","article-title":"The first scale-up production of theranostic nanoemulsions","volume":"4","author":"Liu","year":"2015","journal-title":"BioRes. Open Access"},{"issue":"3","key":"10.1016\/j.jneuroim.2018.02.010_bb0050","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1471-4159.2005.03050.x","article-title":"Up-regulation of interleukin-6 induced by prostaglandin E from invading macrophages following nerve injury: an in vivo and in vitro study","volume":"93","author":"Ma","year":"2005","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.jneuroim.2018.02.010_bb0055","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1517\/14728222.10.4.533","article-title":"Targeting invading macrophage-derived PGE2, IL-6 and calcitonin gene-related peptide in injured nerve to treat neuropathic pain","volume":"10","author":"Ma","year":"2006","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.jneuroim.2018.02.010_bb0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/10408398.2011.559558","article-title":"Food-grade nanoemulsions: formulation, fabrication, properties, performance, biological fate, and potential toxicity","volume":"51","author":"McClements","year":"2011","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.jneuroim.2018.02.010_bb0065","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1002\/jps.23291","article-title":"Scale-up of nanoemulsion produced by emulsification and solvent diffusion","volume":"101","author":"Mitri","year":"2012","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.jneuroim.2018.02.010_bb0070","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3109\/03639045.2011.608681","article-title":"Development of industrially feasible concentrated 30% and 40% nanoemulsions for intravenous drug delivery","volume":"38","author":"Muller","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"2","key":"10.1016\/j.jneuroim.2018.02.010_bb0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2217\/pmt.15.2","article-title":"Additives to local anesthetics for peripheral nerve blocks or local anesthesia: a review of the literature","volume":"5","author":"Opperer","year":"2015","journal-title":"Pain Manag."},{"issue":"2","key":"10.1016\/j.jneuroim.2018.02.010_bb0080","doi-asserted-by":"crossref","first-page":"150","DOI":"10.7150\/thno.9476","article-title":"Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases","volume":"5","author":"Patel","year":"2015","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.jneuroim.2018.02.010_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055802","article-title":"Cyclooxgenase-2 inhibiting perfluoropoly (ethylene glycol) ether theranostic nanoemulsions-in vitro study","volume":"8","author":"Patel","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jneuroim.2018.02.010_bb0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.clim.2015.04.019","article-title":"Theranostic nanoemulsions for macrophage COX-2 inhibition in a murine inflammation model","volume":"160","author":"Patel","year":"2015","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.jneuroim.2018.02.010_bb0095","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nri2528","article-title":"Trophic macrophages in development and disease","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2018.02.010_bb0100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/187221111795471427","article-title":"Therapeutic applications of nanoemulsion based drug delivery systems: a review of patents in last two decades","volume":"5","author":"Rajpoot","year":"2011","journal-title":"Recent Pat. Drug Deliv. Formul."},{"issue":"1","key":"10.1016\/j.jneuroim.2018.02.010_bb0105","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s11481-012-9428-2","article-title":"Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain","volume":"8","author":"Sacerdote","year":"2013","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"4","key":"10.1016\/j.jneuroim.2018.02.010_bb0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/156720105774370267","article-title":"Engineering of nanoemulsions for drug delivery","volume":"2","author":"Sarker","year":"2005","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jneuroim.2018.02.010_bb0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12916-015-0285-8","article-title":"Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis \u2013 an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks","volume":"13","author":"Scarpignato","year":"2015","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2018.02.010_bb0120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.expneurol.2003.09.015","article-title":"Cyclooxygenase inhibition in nerve-injury- and TNF-induced hyperalgesia in the rat","volume":"185","author":"Schafers","year":"2004","journal-title":"Exp. Neurol."},{"issue":"8","key":"10.1016\/j.jneuroim.2018.02.010_bb0125","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1517\/17425247.2012.696605","article-title":"Nanoemulsions as potential vehicles for transdermal and dermal delivery of hydrophobic compounds: an overview","volume":"9","author":"Shakeel","year":"2012","journal-title":"Expert Opin. Drug. Deliv."},{"issue":"16","key":"10.1016\/j.jneuroim.2018.02.010_bb0130","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.108.764530","article-title":"Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials","volume":"117","author":"Solomon","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jneuroim.2018.02.010_bb0135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neulet.2004.03.040","article-title":"Cyclooxygenase-2 expression in Schwann cells and macrophages in the sciatic nerve after single spinal nerve injury in rats","volume":"363","author":"Takahashi","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.jneuroim.2018.02.010_bb0140","doi-asserted-by":"crossref","first-page":"e90589","DOI":"10.1371\/journal.pone.0090589","article-title":"Imaging neuroinflammation in vivo in a neuropathic pain rat model with near-infrared fluorescence and (1)(9)F magnetic resonance","volume":"9","author":"Vasudeva","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2018.02.010_bb0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2015.04.012","article-title":"In vivo and systems biology studies implicate IL-18 as a central mediator in chronic pain","volume":"283","author":"Vasudeva","year":"2015","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2018.02.010_bb0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2010.04.069","article-title":"Cyclooxygenase inhibitors suppress the expression of P2X(3) receptors in the DRG and attenuate hyperalgesia following chronic constriction injury in rats","volume":"478","author":"Wang","year":"2010","journal-title":"Neurosci. Lett."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818300122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818300122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:32:03Z","timestamp":1759048323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572818300122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":30,"alternative-id":["S0165572818300122"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.02.010","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose NSAIDs reduce pain via macrophage targeted nanoemulsion delivery to neuroinflammation of the sciatic nerve in rat","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}